Earlier surgical intervention for mitral valve disease is better for most patients

June 9, 2015, Elsevier

A more aggressive approach to treating degenerative mitral valve disease, using earlier surgical intervention and less invasive techniques, is more beneficial to the patient than "watchful waiting," according to an article in the June 2015 issue of The Annals of Thoracic Surgery.

Key points

  • Earlier using less is better than watchful waiting for patients with degenerative .
  • Over the 25 years observed, mortality rates remained low, hospital length of stay was shorter, and surgical repair became less invasive in the latter years of the study.
  • Researchers said the key to successful treatment is a timely referral for surgical intervention at an advanced repair center with highly skilled heart teams.

Degenerative mitral disease is irreversible. It eventually leads to regurgitation (blood leaking backwards through the valve) and . While surgical treatment of the disease has evolved, there is still debate about the value of watchful waiting versus early surgical repair for patients without symptoms.

Farhang Yazdchi, MD, MS, and colleagues, from the Cleveland Clinic in Ohio, assessed trends in patient characteristics, timing of intervention, and surgical techniques for by reviewing the records of 5,902 patients over a 25-year period (January 1, 1985 to January 1, 2011)..

They found that improved technology and earlier intervention have led to more patients benefitting from less invasive surgical repair before suffering from disease symptoms, such as atrial fibrillation (irregular, often rapid heart rate) or heart failure.

"Surgery is almost unavoidable in patients with severe degenerative mitral valve regurgitation. Our study has shown that the key to successful treatment is a timely referral for surgical intervention at an advanced repair center with highly skilled heart teams," said Dr. Yazdchi.

The researchers found that patients who were treated in the latter years of the study (2005-2011) were released from the hospital about 2 days sooner than those treated in the earliest years of the study (1985-1997). Two main reasons for the shortened stay were fewer full sternotomies (large chest incisions)-25% in the latter years vs. 93% in the earliest years-and more patients were asymptomatic-44% in the latter years vs. 25% in the earliest years.

"Successful at the Cleveland Clinic has reached a level of almost 100%, while mortality rates have remained extremely low and hospital length of stay shortened," said Dr. Yazdchi. "Patients who are diagnosed with severe mitral valve regurgitation should seek surgical consultation sooner rather than later, even if they are not having any symptoms.

Explore further: Heart valve repair improves emotional wellbeing in patients with mitral regurgitation

More information: "Increasing Disadvantage of 'Watchful Waiting' for Repairing Degenerative Mitral Valve Disease," The Annals of Thoracic Surgery DOI: 10.1016/j.athoracsur.2015.01.065

Related Stories

Heart valve repair improves emotional wellbeing in patients with mitral regurgitation

March 17, 2015
Patients with severe mitral regurgitation (MR) often suffer from psycho-emotional symptoms, such as depression and anxiety, but after undergoing mitral valve repair surgery patients experience a marked improvement in emotional ...

Heart valve repair surgery may ease mental health symptoms, too

March 2, 2015
(HealthDay)—People with a serious heart valve defect have less depression and anxiety after they undergo surgery to repair the problem, a new study finds.

Study: New heart valve repair option provides hope for high-risk patients

November 18, 2013
A minimally invasive procedure is the first effective treatment for patients who are at high risk for standard open-heart surgery for a leaking heart valve, a study led by a team of University of Virginia School of Medicine ...

MitraClip valve repair continues to show benefit in commercial setting

March 16, 2015
The commercial track record with transcatheter mitral valve repair, approved for patients at high risk for surgery, compares favorably with pre-approval reports, according to findings from a U.S. registry presented at the ...

Ablation during mitral valve surgery reduces atrial fibrillation

March 16, 2015
Patients with atrial fibrillation who received ablation while they were already undergoing surgery to correct a leaky heart valve had fewer episodes of atrial fibrillation a year later compared to patients who had the valve ...

Study may impact guidelines for mitral valve surgery for severe ischemic mitral regurgitation

November 19, 2013
The Cardiothoracic Surgical Trials Network (CTSN), whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting for the first time evidence on whether or not there is any significant ...

Recommended for you

Resolvin D-1 limits kidney damage after heart attacks

February 20, 2018
A heart attack triggers an acute inflammatory response at the damaged portion of the heart's left ventricle. If this acute inflammation lingers, it can lead to stretching of the ventricle and heart failure. The inflammation ...

Stroke drug demonstrates safety in clinical trial

February 20, 2018
A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, the most common type of stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug invented at The Scripps ...

Women once considered low risk for heart disease show evidence of previous heart attack scars

February 20, 2018
Women who complain about chest pain often are reassured by their doctors that there is no reason to worry because their angiograms show that the women don't have blockages in the major heart arteries, a primary cause of heart ...

Can your cardiac device be hacked?

February 20, 2018
Medical devices, including cardiovascular implantable electronic devices could be at risk for hacking. In a paper publishing online today in the Journal of the American College of Cardiology, the American College of Cardiology's ...

A drug long used to treat gout may help adult heart failure patients

February 20, 2018
Researchers at the University of Cincinnati (UC) College of Medicine have shown that probenecid, a drug long used to treat gout, may be able to improve heart function in adult patients who experience heart failure.

Number of obese years not—just obesity—a distinct risk factor for heart damage

February 20, 2018
In an analysis of clinical data collected on more than 9,000 people, Johns Hopkins researchers have shown that the number of years spent overweight or obese appear to "add up" to a distinct risk factor that makes those with ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.